Your browser doesn't support javascript.
loading
Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells.
Robbins, Yvette; Greene, Sarah; Friedman, Jay; Clavijo, Paul E; Van Waes, Carter; Fabian, Kellsye P; Padget, Michelle R; Abdul Sater, Houssein; Lee, John H; Soon-Shiong, Patrick; Gulley, James; Schlom, Jeffrey; Hodge, James W; Allen, Clint T.
Afiliação
  • Robbins Y; Translational Tumor Immunology Program, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, United States.
  • Greene S; Translational Tumor Immunology Program, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, United States.
  • Friedman J; Translational Tumor Immunology Program, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, United States.
  • Clavijo PE; Translational Tumor Immunology Program, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, United States.
  • Van Waes C; Tumor Biology Section, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, United States.
  • Fabian KP; Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, United States.
  • Padget MR; Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, United States.
  • Abdul Sater H; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, United States.
  • Lee JH; NantKWest, Culver City, United States.
  • Soon-Shiong P; NantKWest, Culver City, United States.
  • Gulley J; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, United States.
  • Schlom J; Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, United States.
  • Hodge JW; Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, United States.
  • Allen CT; Translational Tumor Immunology Program, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, United States.
Elife ; 92020 07 07.
Article em En | MEDLINE | ID: mdl-32633234
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Antígeno B7-H1 / Carcinoma de Células Escamosas de Cabeça e Pescoço Limite: Animals / Humans Idioma: En Revista: Elife Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Antígeno B7-H1 / Carcinoma de Células Escamosas de Cabeça e Pescoço Limite: Animals / Humans Idioma: En Revista: Elife Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos